Regulation of HIV-1 gene expression by the viral Tat transactivator is a cr
itical step in the viral life cycle. Tat acts as a highly unusual transcrip
tion factor that interacts with a stem-loop RNA structure (TAR) found at th
e 5 ' end of all viral transcripts. There, it induces a modification of chr
omatin at the HIV-1 long terminal repeat (LTR) promoter and stimulates the
recruitment of elongation-competent RNA polymerase II complexes capable of
processive transcription. Increase of transcriptional elongation is the con
sequence of the interaction of Tat with cyclin T1, the cyclin component of
CDK9, which phosphorylates the carboxy-terminal domain of RNA polymerase II
to enhance its processivity. Tat-induced transcriptional activation of the
LTR promoter is concomitant with recruitment of the transcriptional coacti
vators p300 and the highly homologue cAMP-responsive transcription factor b
inding protein (CBP). These large proteins act at the level of transcriptio
nal initiation by bridging the basal transcription machinery with specific
transcriptional activators. Furthermore, p300/CBP are histone acetyl-transf
erases capable of modulating the interaction of nucleosomes with DNA and wi
th chromatin remodeling complexes. Besides histones, Tat itself is a substr
ate for the enzymatic activity of p300/CBP and of the associated factor P/C
AF, suggesting a regulatory role of acetylation on the protein itself. Devi
sing a unifying model for LTR activation that includes activities of Tat at
the levels of both transcriptional initiation and transcriptional elongati
on is a challenging task at this moment. Nevertheless, protein localization
studies indicate that both cyclin TI and p300/CBP co-localize in specific
subnuclear compartments, thus suggesting participation of both proteins in
the formation of multimolecular complexes governing coordinated steps of tr
anscriptional activation.